PeptideDB

Citrazinic acid

CAS No.: 99-11-6

Citrazinic acid could inhibit 3-dehydroquinate dehydratase from Mycobacterium tuberculosis. It was also used to synthesi
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Citrazinic acid could inhibit 3-dehydroquinate dehydratase from Mycobacterium tuberculosis. It was also used to synthesize the derivatives of pyrimidinones and oxazinones.
Synonyms 2,6-Dihydroxyisonicotinic acid, Kyselina citrazinova, 2,6-Dihydroxyisonicotinate
molecular weight 155.11
Molecular formula C6H5NO4
CAS 99-11-6
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: Soluble
References 1. Sarkar S, Chowdhury J, Dutta S, Pal T. A pH dependent Raman and surface enhanced Raman spectroscopic studies of citrazinic acid aided by theoretical calculations. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Dec 5;169:108-15. doi: 10.1016/j.saa.2016.06.023. Epub 2016 Jun 16. PubMed PMID: 27344521. 2. Hossan AS, Abu-Melha HM, Al-Omar MA, Amr Ael-G. Synthesis and antimicrobial activity of some new pyrimidinone and oxazinone derivatives fused with thiophene rings using 2-chloro-6-ethoxy-4-acetylpyridine as starting material. Molecules. 2012 Nov 19;17(11):13642-55. doi: 10.3390/molecules171113642. PubMed PMID: 23165308. 3. Masoud MS, Ibrahim AA, Khalil EA, El-Marghany A. Spectral properties of some metal complexes derived from uracil-thiouracil and citrazinic acid compounds. Spectrochim Acta A Mol Biomol Spectrosc. 2007 Jul;67(3-4):662-8. Epub 2006 Aug 25. PubMed PMID: 17029947. 4. Dias MV, Snee WC, Bromfield KM, Payne RJ, Palaninathan SK, Ciulli A, Howard NI, Abell C, Sacchettini JC, Blundell TL. Structural investigation of inhibitor designs targeting 3-dehydroquinate dehydratase from the shikimate pathway of Mycobacterium tuberculosis. Biochem J. 2011 Jun 15;436(3):729-39. doi: 10.1042/BJ20110002. PubMed PMID: 21410435.